Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-006943
Filing Date
2025-02-14
Accepted
2025-02-14 17:01:09
Documents
6

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 531008
2 ex1-2.htm EX-2.1 278020
3 ex5-1.htm EX-5.1 33262
4 ex23-1.htm EX-23.1 3864
5 ex23-2.htm EX-23.2 5676
6 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 39851
  Complete submission text file 0001493152-25-006943.txt   892712
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284990 | Film No.: 25630568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)